HomeCompareSYK vs ET

SYK vs ET: Dividend Comparison 2026

SYK yields 1.04% · ET yields 6.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ET wins by $50.1K in total portfolio value
10 years
SYK
SYK
● Live price
1.04%
Share price
$326.10
Annual div
$3.40
5Y div CAGR
46.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.3K
Annual income
$8,282.98
Full SYK calculator →
ET
ET
● Live price
6.76%
Share price
$19.59
Annual div
$1.33
5Y div CAGR
24.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$93.4K
Annual income
$21,965.29
Full ET calculator →

Portfolio growth — SYK vs ET

📍 ET pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSYKET
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SYK + ET cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SYK pays
ET pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SYK
Annual income on $10K today (after 15% tax)
$88.62/yr
After 10yr DRIP, annual income (after tax)
$7,040.53/yr
ET
Annual income on $10K today (after 15% tax)
$574.91/yr
After 10yr DRIP, annual income (after tax)
$18,670.50/yr
At 15% tax rate, ET beats the other by $11,629.96/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SYK + ET for your $10,000?

SYK: 50%ET: 50%
100% ET50/50100% SYK
Portfolio after 10yr
$68.3K
Annual income
$15,124.13/yr
Blended yield
22.13%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SYK right now

SYK
Analyst Ratings
1
Strong
35
Buy
14
Hold
Consensus: Buy
Price Target
$428.67
+31.5% upside vs current
Range: $390.00 — $469.00
Altman Z
4.0
Piotroski
5/9
ET
Analyst Ratings
1
Strong
27
Buy
4
Hold
Consensus: Buy
Price Target
$18.00
-8.1% upside vs current
Range: $17.00 — $19.00
Altman Z
1.3
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SYK buys
0
ET buys
0
No recent congressional trades found for SYK or ET in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSYKET
Forward yield1.04%6.76%
Annual dividend / share$3.40$1.33
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR46.2%24.5%
Portfolio after 10y$43.3K$93.4K
Annual income after 10y$8,282.98$21,965.29
Total dividends collected$21.0K$64.0K
Payment frequencyquarterlyquarterly
SectorHealthcareEnergy
Analyst consensusBuyBuy
Analyst price target$428.67$18.00

Year-by-year: SYK vs ET ($10,000, DRIP)

YearSYK PortfolioSYK Income/yrET PortfolioET Income/yrGap
1← crossover$10,852$152.43$11,542$842.08$690.00ET
2$11,838$226.03$13,481$1,130.89$1.6KET
3$13,004$336.89$15,961$1,536.88$3.0KET
4$14,420$505.63$19,196$2,117.29$4.8KET
5$16,195$766.09$23,503$2,962.82$7.3KET
6$18,504$1,175.64$29,369$4,220.80$10.9KET
7$21,635$1,835.40$37,561$6,136.87$15.9KET
8$26,082$2,932.10$49,323$9,132.50$23.2KET
9$32,737$4,829.68$66,729$13,953.56$34.0KET
10$43,312$8,282.98$93,366$21,965.29$50.1KET

SYK vs ET: Complete Analysis 2026

SYKHealthcare

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Full SYK Calculator →

ETEnergy

Energy Transfer LP provides energy-related services. The company owns and operates approximately 11,600 miles of natural gas transportation pipeline, and three natural gas storage facilities in Texas and two natural gas storage facilities located in the state of Texas and Oklahoma; and 19,830 miles of interstate natural gas pipeline. It also sells natural gas to electric utilities, independent power plants, local distribution and other marketing companies, and industrial end-users. The company owns and operates natural gas gathering and natural gas liquid (NGL) pipeline, processing plant, and treating and conditioning facilities in Texas, New Mexico, West Virginia, Pennsylvania, Ohio, Oklahoma, Arkansas, Kansas, and Louisiana; natural gas gathering, oil pipeline, and oil stabilization facilities in South Texas; and a natural gas gathering system in Ohio, as well as transport and supplies water to natural gas producer in Pennsylvania. It owns approximately 5,215 miles of NGL pipeline; NGL and propane fractionation facilities; NGL storage facilities with working storage capacity of approximately 50 million barrels (MMBbls); and other NGL storage assets and terminal with an aggregate storage capacity of approximately 17 MMBbls. The company provides crude oil transportation, terminalling, acquisition, and marketing activities; and sells and distributes gasoline, middle distillate, and motor fuels and other petroleum product. It offers natural gas compression service; carbon dioxide and hydrogen sulfide removal, natural gas cooling, dehydration, and British thermal unit management service; and manages coal and natural resources properties, as well as sells standing timber, leases coal-related infrastructure facilities, collects oil and gas royalty, and generate electrical power. The company was formerly known as Energy Transfer Equity, L.P. and changed its name to Energy Transfer LP in October 2018. The company was founded in 1996 and is headquartered in Dallas, Texas.

Full ET Calculator →
📬

Get this SYK vs ET comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SYK vs SCHDSYK vs JEPISYK vs OSYK vs KOSYK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.